|
Wednesday, March 30, 2011
Agenda
| 1:30 PM - 2:00 PM |
Registration and Networking |
| 2:00 PM - 3:00 PM |
Navigating Through International Patent Filings |
| 3:00 PM - 3:15 PM |
Break |
| 3:15 PM – 4:45 PM |
Trends and Issues in the Health and Life Science Industry |
| 4:45 PM – 5:30 PM |
Networking Reception |
OVERVIEW
Must Knows for Protecting Your Company's Assets
The smart move when developing an IP Strategy is one that considers your full potential while delivering maximum protection of your patentable assets. Startups rarely have the resources to dedicate to develop a comprehensive IP strategy; therefore the BioCenter is pleased to partner with Kilpatrick Townsend in a series of IP specific programs that will provide startups with the keys and resources critical to setting your company up for success.
In the first session, participants will learn about an international patent filing strategy that can accelerate the general patent application process -- a must know in today’s global economy. This session will also discuss current domestic healthcare trends and issues that will undoubtedly impact your growing organization.
Our programs are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself.
SPEAKER
- Robert C. Harmala, Partner, Kilpatrick Townsend
- William B. Kezer Ph.D., Partner, Kilpatrick Townsend
- Phillip H. Street, Partner, Kilpatrick Townsend
VENUE
Garden Court Hotel
520 Cowper Street
Downtown Palo Alto, CA
Click here for Venue Directions»
SPEAKER BIO
Robert C. Harmala, Partner, Kilpatrick Townsend
Robert Harmala focuses his practice on government relations at the federal, state and local levels. Mr. Harmala's legislative and legal experience spans a diverse array of subject areas including Native American affairs, intellectual property, international relations, appropriations, tax, the laws of the European Union, transportation, telecommunications, media and advertising.
In addition to his federal representation, Mr. Harmala also provides advocacy services to clients before the California legislature as well as other political entities in California. Mr. Harmala has practiced both in large law firms and as a sole practitioner. As a sole practitioner with an office in the Netherlands, he advised U.S. clients on the laws of the European Union as well as political intelligence on EU decision making.
Mr. Harmala is an active participant in Democratic politics and has worked in various capacities with the Democratic Parties of California, South Dakota, Wyoming and Kentucky.
Professional & Community Activities
Former counsel to the House Foreign Affairs Committee, Staff of Representative Howard Berman (D-CA)
Philip C. Jessup Moot Court Competition, Former Member
Education
• University of Southern California, J.D. (1994)
• University of California, Berkeley, A.B. (1991)
Bar Admissions
• District of Columbia (1996)
• California (1995)
Court Admissions
• U.S. Court of Appeals for the Ninth Circuit (2002)
William B. Kezer, Ph.D., Partner, Kilpatrick Townsend
Dr. William Kezer is co-chair of Kilpatrick Townsend's Chemistry & Biotechnology Practice Group. Dr. Kezer advises clients in all aspects of patent prosecution, with an emphasis on chemistry, particularly pharmaceutical products and targets, as well as other small molecules (e.g., dyes, probes and binding agents). He has worked extensively in the strategic development of patent portfolios and has provided due diligence reviews of targeted companies and technology. Comparative evaluation of competitive patented technologies for our clients is yet another aspect of Dr. Kezer's practice.
Dr. Kezer's practice also focuses on procuring global patent protection for pharmaceutical inventions and providing strategies for product protection that include formulations, drug delivery technologies and dosing methods.
Dr. Kezer is currently the Vice Chairman for the AIPLA Chemical Practice Committee, and has previously served as in-house Patent Counsel for Tularik Inc. (now part of Amgen, Inc.), a company involved in the discovery of compounds for the regulation of gene expression. His experience in the corporate setting has been useful for providing a business-based, product-driven approach to patent portfolio construction.
Prior to entering the practice of law, Dr. Kezer served as a Senior Research Scientist and Project Leader for FMC Corporation and Dow Chemical Company/DowElanco. His research experience involved the design and synthesis of small molecule regulators of biological processes. Dr. Kezer's doctoral thesis was directed to the design and synthesis of transition-state analogs as inhibitors of peptidases, under the direction of Professor Paul A. Bartlett at the University of California, Berkeley.
Education
• Golden Gate University School of Law, J.D. (1993)
• University of California, Berkeley, Ph.D., Organic Chemistry (1983)
• Humboldt State University, B.S., Chemistry (1978)
Bar Admissions
• California
Court Admissions
• U.S. Patent and Trademark Office
Phillip H. Street, Partner, Kilpatrick Townsend
Phillip Street has practiced law in the life sciences/health care field since 1986. His primary areas of practice include health care and life sciences transactions, including business formations, strategic alliances, venture financings, mergers, acquisitions and joint ventures and the commercialization of life sciences research. He serves as legal advisor to hospital systems and life sciences companies, medical research organizations (pre-clinical and clinical), physician research consortiums, pharmaceutical and biotechnology corporations, medical device companies, academic medical research universities, physician organizations, health care providers, and other health care and life sciences-related entities.
Mr. Street provides general counseling to health care organizations and life sciences companies. He has over fifteen years of experience in the commercialization of research and bio-informatic technologies – advising through all growth stages from startup to mature public or private companies, including venture capital funding, licensing, joint ventures, development arrangements and strategic alliances. He regularly counsels organizations (non-profit and for profit) in connection with ongoing compliance matters, regulatory matters, tax exemption issues and commercialization issues. He also counsels companies on product development issues, regulatory analysis, and marketing/sales practices including matters involving health information privacy and matters arising under the Federal health care program’s anti-kickback statute, and Federal civil false claims act. Mr. Street has extensive experience in structuring joint ventures and integrations between physicians and hospitals; the formation and structuring of large single and multi-specialty physician groups, practice management companies, and physician affiliation opportunities; development and licensure of provider-sponsored health care/research corporations and HMOs; provider network development and integration; and the acquisition, merger and sale of all types of health care facilities. He also counsels health care organizations regarding ongoing regulatory compliance and tax exemption issues.
Mr. Street has been listed in Chambers USA: America's Leading Lawyers for Business for health care every year since 2005. Mr. Street was recognized as a Georgia "Super Lawyer" in Health Care in 2009 and 2010 and Business and Corporate Law in 2009 by SuperLawyers magazine as well as a "Georgia Super Lawyer" by Atlanta Magazine in 2008, 2009 and 2010, which recognizes the top five percent of attorneys in the state. He was also recognized in The Best Lawyers in America® for Health Care Law in 2011 and the three years immediately preceding. Mr. Street was recognized as a 2010 Atlanta Business Leader IMPACT honoree by Business to Business Magazine. He is listed in the Atlanta Business Chronicle’s “Who’s Who in Health Care,” recognized by Tech Journal South as one of the "25 of the Most Influential People in the Southeast Technology Community," and AV® rated by Martindale-Hubbell.*
*CV, BV, and AV are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedure's standards and policies.
Professional & Community Activities
American Health Lawyers Association, Member
Atlanta Tax Forum, Member
Bioscience Leadership Council, Medical Device Subcommittee, Member
Georgia Bio, Executive Committee, Board Member and Corporate Counsel
Grady Health System, Board of Visitors Member
Metro Atlanta Chamber, Bioscience Industry Leadership Council Member
BIO International Convention for 2009, Steering Committee Member
Southeast BIO/Southeast, Recent Past Chair and Ex-Officio Chair of the Board of Directors
Education
• Vanderbilt University, J.D. (1986)
• New York University, LL.M., Taxation (1989)
• Vanderbilt University, B.A., Economics (1982)
Bar Admissions
• Not Licensed in North Carolina
• Alabama (1986)
• Georgia (1989)
|
